Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 141.61
0.79 %
$ 20.7 B
Market Cap
12.67
P/E
Price Target
Average
87.08%
Revenue Forecast
Estimate
--0.18%
EBIT
Estimate
--19.51%
Net Income
Estimate
13.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Biogen Inc.
Wall Street analysts predict an average 1-year price target for BIIB of $265 , with forecasts ranging from
a
low of
$160 to a high of $342 .
BIIB Lowest Price Target
Wall Street Target
160 USD
12.99%
BIIB Average Price Target
Wall Street Target
265 USD
87.08%
BIIB Highest Price Target
Wall Street Target
342 USD
141.51%
REVENUE FORECAST
Revenue Forecast Chart BIIB
EBIT FORECAST
EBIT Forecast Chart BIIB
NET INCOME FORECAST
Net Income Chart BIIB